Dobutamine HCL

Purui’s Dobutamine HCL (CAS 34368-04-2) is a pharmaceutical-grade β1 receptor agonist that meets USP and EP11.0 standards. It selectively enhances myocardial contractility, improves cardiac output without significant increases in heart rate or oxygen consumption, making it a first-line choice for treating acute heart failure and hemodynamic instability. As an experienced exporter, we offer Bulk Order Dobutamine HCL services and ensure Dobutamine HCL in Stock year-round to respond to urgent procurement needs of emergency drug production and clinical rescue. Our product undergoes rigorous quality control, with ultra-low impurity content and stable efficacy to guarantee safety in critical medical scenarios.

Product Parameters (Specification)

Product Features and Applications

Product Features:

Precise myocardial targeting: High selectivity for β1 receptors, effectively enhancing cardiac contractility without causing excessive vasoconstriction or arrhythmia, reducing clinical risks;

Emergency scenario adaptability: Rapid onset of action (10-20 minutes after administration) and short half-life, facilitating flexible dose adjustment during rescue;

Strong formulation compatibility: Stable chemical properties, suitable for developing injectable preparations (intravenous injections, lyophilized powder for injection) and compatible with common clinical infusion solutions;

Global regulatory recognition: Complies with USP and EP11.0 standards, supporting the registration and marketing of finished products in major pharmaceutical markets worldwide.

Application Scenarios:

Acute heart failure: Used for treating decompensated heart failure, acute left ventricular failure, and heart failure exacerbation, improving cardiac output and relieving pulmonary edema;

Hemodynamic support: Adjuvant treatment for cardiogenic shock, septic shock complicated with myocardial depression, and post-cardiac surgery low cardiac output syndrome;

Critical care: Hemodynamic regulation in ICUs for patients with severe infections, trauma, or post-operative cardiac dysfunction;

Pharmaceutical formulation: Core raw material for emergency injectable drugs, meeting the demand for life-saving medications in hospitals, emergency centers, and disaster relief scenarios.

Procurement and Service Support

As your trusted Dobutamine HCL Exporter, we provide tailored procurement solutions for cardiovascular pharmaceutical raw materials:

Flexible Bulk Order policies: Competitive pricing for large-volume purchases, with preferential terms for long-term strategic partners in the emergency drug industry;

Reliable in-stock guarantee: Dobutamine HCL in Stock covers multiple batches, supporting same-day shipment for urgent orders and professional cold-chain logistics to maintain product stability;

Comprehensive documentation support: Provide USP/EP11.0-compliant quality inspection reports, certificate of analysis (COA), and customs clearance documents to meet regulatory and supply chain audit requirements;

Technical consultation: Professional team offers guidance on formulation development, compatibility with infusion solutions, and storage precautions, ensuring smooth application in pharmaceutical production and clinical use.

FAQ

Q1：What is the primary clinical application of Dobutamine HCL?

A1：It is mainly used to treat low cardiac output caused by myocardial infarction, heart failure and cardiac surgery, serving as a positive inotropic agent to strengthen myocardial contraction.

Q2：In which emergency and critical care scenarios is Dobutamine HCL commonly used?

A2：It is widely applied in intensive care units for hemodynamic support, especially for patients with cardiogenic shock and decompensated heart failure.

Q3：What is the application value of Dobutamine HCL in pharmaceutical and research fields?

A3：It is used as a key API raw material for cardiovascular injections, and also applied in pharmacological research on myocardial function and drug efficacy evaluation.